<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Nanomedicine</journal-id><journal-title-group><journal-title>International Journal of Nanomedicine</journal-title></journal-title-group><issn pub-type="ppub">1176-9114</issn><issn pub-type="epub">1178-2013</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22238506</article-id><article-id pub-id-type="pmc">3254262</article-id><article-id pub-id-type="doi">10.2147/IJN.S26070</article-id><article-id pub-id-type="publisher-id">ijn-6-3163</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Effect of heparan sulfate and gold nanoparticles on muscle development during embryogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zielinska</surname><given-names>Marlena</given-names></name><xref ref-type="aff" rid="af1-ijn-6-3163">1</xref><xref ref-type="aff" rid="af2-ijn-6-3163">2</xref></contrib><contrib contrib-type="author"><name><surname>Sawosz</surname><given-names>Ewa</given-names></name><xref ref-type="aff" rid="af1-ijn-6-3163">1</xref></contrib><contrib contrib-type="author"><name><surname>Grodzik</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="af1-ijn-6-3163">1</xref></contrib><contrib contrib-type="author"><name><surname>Wierzbicki</surname><given-names>Mateusz</given-names></name><xref ref-type="aff" rid="af1-ijn-6-3163">1</xref></contrib><contrib contrib-type="author"><name><surname>Gromadka</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="af1-ijn-6-3163">1</xref></contrib><contrib contrib-type="author"><name><surname>Hotowy</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="af3-ijn-6-3163">3</xref></contrib><contrib contrib-type="author"><name><surname>Sawosz</surname><given-names>Filip</given-names></name><xref ref-type="aff" rid="af3-ijn-6-3163">3</xref></contrib><contrib contrib-type="author"><name><surname>Lozicki</surname><given-names>Andrzej</given-names></name><xref ref-type="aff" rid="af1-ijn-6-3163">1</xref></contrib><contrib contrib-type="author"><name><surname>Chwalibog</surname><given-names>Andr&#x000e8;</given-names></name><xref ref-type="aff" rid="af3-ijn-6-3163">3</xref><xref ref-type="corresp" rid="c1-ijn-6-3163"/></contrib></contrib-group><aff id="af1-ijn-6-3163"><label>1</label>Division of Biotechnology and Biochemistry of Nutrition, Warsaw University of Life Sciences, Warsaw</aff><aff id="af2-ijn-6-3163"><label>2</label>The Kielanowski Institute of Animal Physiology and Nutrition, Jablonna, Poland</aff><aff id="af3-ijn-6-3163"><label>3</label>Department of Basic Animal and Veterinary Sciences, University of Copenhagen, Frederiksberg, Denmark</aff><author-notes><corresp id="c1-ijn-6-3163">Correspondence: Andr&#x000e9; Chwalibog, University of Copenhagen, Department of Basic Animal and Veterinary Sciences, Groennegaardsvej 3, 1870 Frederiksberg, Denmark, Tel +45 3533 3044, Fax +45 3533 3020, Email <email>ac@life.ku.dk</email></corresp></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><!--Dove Press titles changed from ppub to collections in 2009.
								Fake ppub written to satisfy Coll Date Type=ppub--><pub-date pub-type="ppub"><year>2011</year></pub-date><pub-date pub-type="epub"><day>06</day><month>12</month><year>2011</year></pub-date><volume>6</volume><fpage>3163</fpage><lpage>3172</lpage><permissions><copyright-statement>&#x000a9; 2011 Zielinska et al, publisher and licensee Dove Medical Press Ltd</copyright-statement><copyright-year>2011</copyright-year><license><license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>It was hypothesized that heparan sulfate (HS) as an essential compound for myogenesis and nanoparticles of gold (nano-Au) as highly reactive compounds can affect muscle development as a consequence of molecular regulation of muscle cell formation, and that these effects may be enhanced by a complex of HS conjugated with nano-Au. The objective of the present study was to determine the effect of administration of nano-Au, HS, and a nano-Au+HS complex on the morphological and molecular characteristics of breast muscle during embryogenesis.</p></sec><sec><title>Methods</title><p>Chicken embryos were used as in vivo model. Fertilized chicken eggs (n = 350) were randomly divided into the control group and the groups treated with nano-Au, HS, and nano-Au+HS. The experimental solutions were given in ovo on the first day of incubation and the embryos were evaluated on day 20 of incubation. The methods included biochemical indices in blood, immunohistochemistry, microscopy (transmission electron microscopy, scanning electron microscopy, confocal), and gene expression at the messenger ribonucleic acid and protein levels.</p></sec><sec><title>Results</title><p>The treatments did not adversely affect mortality, organ weight, and homeostasis of the embryos. HS stimulated the development and maturation of breast muscle by increasing the number of nuclei, satellite cells, and muscle fibers and affected the expression of basic fibroblast growth factor-2 and paired-box transcription factor-7. Furthermore, the nano-Au+HS complex contributed to the increased number of myocytes and nuclei in chicken embryo muscles.</p></sec><sec><title>Conclusion</title><p>The results indicate that the administration of HS and nano-Au affects muscle development and that this effect is enhanced by conjugating HS with nano-Au.</p></sec></abstract><kwd-group><kwd>gold nanoparticles</kwd><kwd>heparan sulfate</kwd><kwd>muscle development</kwd><kwd>embryogenesis</kwd><kwd>chicken</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Myogenesis is the key process of muscle development occurring during embryogenesis, with the final number of muscle cells nearly established just before birth. Myogenesis begins with the conversion of pluripotent cells into myoblast precursors, which, depending on extracellular signals, undergo migration or proliferation. Afterwards, the precursors stop dividing and some form uninuclear totipotential cells, ie, satellite cells, while the remaining myoblasts begin to differentiate. Subsequently, they undergo fusion to form multinucleated myotubes, which become muscle cells. The process of formation of muscle is almost completed at the time of hatching, and the numbers of muscle fibers and nuclei in muscle cells are almost fixed.<xref ref-type="bibr" rid="b1-ijn-6-3163">1</xref>,<xref ref-type="bibr" rid="b2-ijn-6-3163">2</xref> Satellite cells are potentially mitotically active myogenic cells, located at the periphery of muscle fibers, between the sarcolemma and the basement membrane of developed muscle fibers. In contrast to muscle cells, satellite cells retain the capacity for DNA replication and mitotic division, and have the ability to proliferate in response to muscle damage, hence they support the process of muscle regeneration in postnatal life.<xref ref-type="bibr" rid="b3-ijn-6-3163">3</xref> In the muscles of birds, satellite cells appear between day 13 and day 16 of embryogenesis.<xref ref-type="bibr" rid="b4-ijn-6-3163">4</xref></p><p>The factor responsible for renewing the pool of satellite cells is the protein paired-box transcription factor-7 (<italic>Pax-7</italic>).<xref ref-type="bibr" rid="b1-ijn-6-3163">1</xref> It affects the transcriptional activation of genes and regulates the development of myogenic cells.<xref ref-type="bibr" rid="b5-ijn-6-3163">5</xref> In <italic>Pax-7</italic>-deficient neonatal mice, a lack of satellite cells in crossstriated skeletal muscles was observed, suggesting that this is a key factor responsible for the formation of satellite cells,<xref ref-type="bibr" rid="b6-ijn-6-3163">6</xref> and is therefore an excellent marker of satellite cell development.<xref ref-type="bibr" rid="b7-ijn-6-3163">7</xref></p><p>During embryogenesis, the activity of myoblasts and satellite cells is highly affected by the extracellular matrix, consisting of an organized network of proteins and polysaccharides (collagen, proteoglycans, and glycoproteins).<xref ref-type="bibr" rid="b2-ijn-6-3163">2</xref> Proteoglycans play an important role in the differentiation of muscle, regulating the reactivity of myoblasts and satellite cells by acting on basic fibroblast growth factor-2 (<italic>FGF-2</italic>) and the family of transforming growth factors.<xref ref-type="bibr" rid="b8-ijn-6-3163">8</xref> The interaction between muscle cells and <italic>FGF-2</italic> depends on several factors, including the presence of heparan sulfate (HS) in the extracellular matrix. HS mediates interactions with a variety of extracellular ligands and participates in the proliferation, differentiation, migration, and adhesion of cells.<xref ref-type="bibr" rid="b9-ijn-6-3163">9</xref> The genetic capacity for proper development of muscle tissue in embryos of animals and humans may be hampered by a shortage of sulfur signaling compounds in the extracellular matrix, especially glycosaminoglycans.<xref ref-type="bibr" rid="b10-ijn-6-3163">10</xref></p><p>The unique properties of gold nanoparticles (nano-Au) are due to their small size, much larger surface area per unit mass compared with larger particles, and a greater proportion of atoms exposed on the surface of the particles, making them much more reactive than larger particles.<xref ref-type="bibr" rid="b11-ijn-6-3163">11</xref> Nano-Au exhibit a strong affinity for thiol groups, which allows efficient and selective bonding with intracellular compounds.<xref ref-type="bibr" rid="b12-ijn-6-3163">12</xref> Nano-Au can penetrate cells by endocytosis, and they can be carriers of pharmaceuticals, nucleic acids, and other biologically active substances.<xref ref-type="bibr" rid="b13-ijn-6-3163">13</xref>,<xref ref-type="bibr" rid="b14-ijn-6-3163">14</xref> The application of drugs conjugated with nano-Au has shown high precision in the delivery of drugs, and significantly decreased their doses.<xref ref-type="bibr" rid="b15-ijn-6-3163">15</xref></p><p>It has been demonstrated that low concentrations of nano-Au are not toxic to human cells,<xref ref-type="bibr" rid="b16-ijn-6-3163">16</xref> but cause toxicity in zebrafish<xref ref-type="bibr" rid="b17-ijn-6-3163">17</xref> and when using higher doses deposited in animal tissues.<xref ref-type="bibr" rid="b18-ijn-6-3163">18</xref> The present experiment was not designed to evaluate potential toxicity of nano-Au but to measure their effects on muscle development when used in a small concentration (50 mg/L solution).</p><p>Nano-Au can create biocomplexes with organic compounds in the process of self-assembly (self-organization) using noncovalent bonds.<xref ref-type="bibr" rid="b19-ijn-6-3163">19</xref>,<xref ref-type="bibr" rid="b20-ijn-6-3163">20</xref> The phenomenon of self-organization allows the creation of new structures in a simple and natural way, and in this respect, nano-Au seem to be a promising candidate for self-assembly processing of biomolecules like HS.</p><p>It was hypothesized that HS as an essential compound for myogenesis and nano-Au as highly reactive compounds can affect muscle development as a consequence of molecular regulation of muscle cell formation, and that these effects may be enhanced by a complex of HS conjugated with nano-Au. The objective of the present study was to determine the effect of administration of HS, nano-Au, and the nano-Au+HS complex on the morphological and molecular characteristics of muscle development, particularly on the number of muscle and satellite cells.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Solutions</title><p>The hydrocolloid of nano-Au (50 mg/L) obtained from Nano-Tech (Warsaw, Poland) was produced by an electric nonexplosive patented method (Polish patent 3883399) from high purity metals (99.99%) and high purity demineralized water. The structure of the nanoparticles was visualized by a JEM-1220 transmission electron microscope (TEM) (JEOL, Tokyo, Japan) and the diameter ranged from 5&#x02013;70 nm (<xref ref-type="fig" rid="f1-ijn-6-3163">Figure 1</xref>). HS was provided by Iduron Ltd (Manchester, United Kingdom) as a K5 polysaccharide derivative. Produced in <italic>Escherichia coli</italic> K5, it has a repeat unit structure identical to the nonsulfated regions of HS. The highly sulfated derivative was applied where sulfation was carried out by chemical and enzymatic methods. This polymer was N-sulfated, O-sulfated at C-6 of &#x003b1;-N-sulfo-D-glucosamine, C2 and C3 of glucuronic acid, and had variable O-sulfation at C3 of &#x003b1;-N-sulfo-D-glucosamine.</p><p>HS was conjugated with nano-Au by mixing the HS water solution (0.032 mg/L) with nano-Au hydrocolloid (50 mg/L) in an ultrasonic bath (Sonorex Super RK 514 H; Bandelin Electronic, Berlin, Germany) for 30 minutes at 36&#x000b0;C at a frequency of 50/60 Hz.</p></sec><sec><title>Experiment</title><p>Fertilized chicken eggs (n = 350) were randomly divided into four treatment groups: (1) control group (without injection), (2) nano-Au group (with nano-Au solution), (3) HS group (with HS solution), and (4) nano-Au+HS group (with mixture of nano-Au and HS). The experimental solutions were given in ovo on the first day of incubation by injecting 500 &#x003bc;L of each solution into the air sack.</p><p>The embryos were evaluated on day 20 of incubation. The embryos were weighed together with the yolk sack, decapitated, and blood samples from the carotid artery were with-drawn and collected in Eppendorf polymerase chain reaction (PCR) tubes (Eppendorf AG, Hamburg, Germany). Samples were incubated at room temperature until clotting and then centrifuged for 10 minutes (14,500 &#x000d7; g). The resulting blood serum samples were stored at &#x02212;30&#x000b0;C until further analysis. The liver, heart, and spleen were collected and weighed. Samples of the breast muscles (4 &#x000d7; 6 &#x000d7; 2 mm) were collected in liquid nitrogen for immunohistochemistry, enzyme-linked immunosorbent assay, and confocal microscopy preparations or fixed in glutaraldehyde for electron microscopy preparation or collected in RNAlater<sup>&#x000ae;</sup> ribonucleic acid (RNA) Stabilization Solution (Applied Biosystems/Ambion, Austin, TX) for gene expression analysis.</p><p>The experimental procedures were approved by, and complied with the guidelines of, the National Ethical Committee of Animal Experimentation, Poland.</p></sec><sec sec-type="methods"><title>Analytical methods</title><sec><title>Evaluation of embryo development</title><p>Embryo development was evaluated on day 20 of embryogenesis. The morphological structure was compared with the standard described by Hamburger and Hamiliton.<xref ref-type="bibr" rid="b21-ijn-6-3163">21</xref></p><p>Concentrations of magnesium, calcium, phosphorus, triglycerides, cholesterol in very-low-density lipoprotein, glucose, and the activities of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and lactate dehydrogenase in blood serum were measured by dry chemistry methods using the chemical analyzer Johnson and Johnson Vitros<sup>&#x000ae;</sup> DT60 II (Ortho-Clinical Diagnostics Inc, Raritan, NJ).</p></sec><sec><title>Immunohistochemistry</title><p>Frozen (&#x02212;80&#x000b0;C) breast muscles were cut on a cryostat (Leica CM1900; Leica Microsystems GmbH, Wetzlar, Germany) into 7 &#x003bc;m thick sections and put on microscopic slides covered with poly-L-lysine (Waldemaar Knittel Gl&#x000e4;sbearbeitungs, Braunschweig, Germany). Fixation was performed in 4% paraformaldehyde for 30 minutes and then in 0.5% Tween<sup>&#x000ae;</sup> 20 (Bio-Rad Laboratories, Hercules, CA) for 5 minutes. Fixed slides were kept at &#x02212;20&#x000b0;C until further processing.</p><p>Specimens were hydrated with 10 minutes incubation in phosphate buffered saline (PBS; Sigma-Aldrich Corporation, St Louis, MO) at room temperature. Staining was performed in the dark, using a solution containing 1 &#x003bc;g/mL 4&#x02032;,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) in PBS. The incubation lasted for 20 minutes and was followed by a triple rinse of the slides with PBS. The specimens were then coverslipped using ProLong<sup>&#x000ae;</sup> Gold Antifade Reagent (Life Technologies, Carlsbad, CA).</p><p>Fixed preparations were hydrated for 10 minutes in PBS at room temperature. Specimens were then incubated in a solution containing 2% goat serum (Sigma-Aldrich) and 1% bovine serum albumin (Sigma-Aldrich) for 20 minutes at room temperature to block nonspecific binding. In the next step, the specimens were incubated with the primary antibody (<italic>Pax-7</italic>; Santa Cruz Biotechnology, Inc, Santa Cruz, CA) diluted 1:200 for 60 minutes at room temperature. Subsequently, excess antibodies were washed off with three rinses of PBS and the secondary antibody (antimouse immunoglobulin G&#x02013;fluorescein isothiocyanate antibody produced in goat; Sigma-Aldrich) diluted 1:1000 was applied. After a triple rinse of the slides in PBS, DAPI staining was performed.</p></sec><sec><title>Microscopy</title><p>Immunohistochemically stained specimens were visualized using a FluoView FV-1000 confocal microscope equipped with FV10-ASW version 1.4. software (Olympus Corporation, Warsaw, Poland). The pictures were analyzed using the cellSens<sup>&#x000ae;</sup> Dimension program (Olympus).</p><p>The breast muscles were examined using a Quanta<sup>&#x02122;</sup> 200 scanning electron microscope (SEM; FEI Company, Hillsboro, OR), using environmental SEM operating mode and by TEM. For observations with SEM, samples were stored at &#x02212;30&#x000b0;C. Frozen (&#x02212;30&#x000b0;C) samples were cleanly cut with a scalpel into 1 mm thick sections on frozen pieces of wax. While still frozen, a sample section was placed on a Peltier table within a standard cooled microscope column (at &#x02212;5&#x000b0;C for blood vessels and &#x02212;10&#x000b0;C for cartilage) in the sample chamber under high vacuum (10<sup>&#x02212;5</sup> Torr). For observations with TEM, immediately after dissection, tissues were cut into pieces of about 1 mm<sup>3</sup> and fixed in a 2.5% glutaraldehyde solution (Sigma-Aldrich) in 0.1 M phosphate buffer (pH 6.9). Samples were then rinsed in the same buffer and transferred to a 1% osmium tetroxide solution (Sigma-Aldrich) in 0.1 M phosphate buffer (pH 6.9) for 1 hour. Subsequently, the samples were rinsed in distilled water, dehydrated in an ethanol gradient, and impregnated with epoxy embedding resin (Fluka Epoxy Embedding Medium Kit; Sigma-Aldrich). The next day, samples were embedded in the same resin and baked for 24 hours at 36&#x000b0;C. The blocks were then transferred to a 60&#x000b0;C incubator and baked for another 24 hours. The blocks were cut into ultrathin sections (50&#x02013;80 nm) using an ultramicrotome (Ultratome III; LKB Products, Bromma, Sweden) and transferred onto copper grids, 200 mesh (Agar Scientific Ltd, Stansted, Essex, United Kingdom). Subsequently, the sections were contrasted using uranyl acetate dihydrate (Sigma Aldrich) and lead citrate (lead (II) citrate tribasic trihydrate; Sigma-Aldrich).</p></sec><sec><title>Gene expression of <italic>Pax-7</italic> and <italic>FGF-2</italic> at messenger RNA (mRNA) level</title><p>The tissue dissected from the breast muscle was homogenized in TRIzol<sup>&#x000ae;</sup> Reagent (Life Technologies), and total RNA was extracted according to the manufacturer&#x02019;s instructions. The RNA samples were purified, using the SV Total RNA Isolation System (Promega Corporation, Madison, WI) and quantified using a NanoDrop ND 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA). Using reverse transcriptase with oligo(dT) (Promega) and random primers (TAG Copenhagen A/S, Copenhagen, Denmark), 2 mg of total RNA was reverse transcribed, after which real-time PCR was performed with complementary DNA and gene-specific primer pairs (TAG Copenhagen; <xref ref-type="table" rid="t1-ijn-6-3163">Table 1</xref>) mixed with LightCycler<sup>&#x000ae;</sup>480 SYBR Green I Master mix (Roche Applied Science, Penzberg, Germany) in a LightCycler<sup>&#x000ae;</sup>480 Real-Time PCR system (Roche Applied Science). The samples were first denatured for 5 minutes at 95&#x000b0;C and then amplified using 45 cycles of 10 seconds at 95&#x000b0;C (denaturation), 10 seconds at 60&#x000b0;C&#x02013;62&#x000b0;C (annealing), and 9 seconds at 72&#x000b0;C (elongation), followed by quantification. A melting curve program (56&#x000b0;C&#x02013;97&#x000b0;C with a heating rate of 0.11&#x000b0;C/ second and five acquisitions per 1&#x000b0;C) was applied to verify the specificity of the product. For each complementary DNA, the reaction was performed in triplicate. For analyses, relative quantification was applied with <italic>ACTB</italic> and <italic>EEF1</italic>-&#x003b1; used as the housekeeping genes.</p></sec><sec><title>Gene expression of <italic>FGF-2</italic> at protein level</title><p>Frozen breast muscle tissue samples were homogenized on ice using RIPA lysis and extraction buffer (Thermo Fisher Scientific) and a Polytron<sup>&#x000ae;</sup> PT 2100 homogenizer (Kinematica AG, Lucerne, Switzerland). Homogenates were left on ice for 30 minutes and were subsequently centrifuged for 20 minutes (4&#x000b0;C, 12,500 rpm). The supernatant was collected in chilled Eppendorf PCR tubes (Eppendorf AG). Supernatant samples were divided into two equal portions. One was used to evaluate the total protein concentration (Total Protein Kit, Micro Lowry, Peterson&#x02019;s Modification; Sigma-Aldrich). The second portion was used to perform the enzyme-linked immunosorbent test, using an Enzyme-linked Immunosorbent Assay Kit for Gallinaceous FGF-2 (USCN Life Science, Tokyo, Japan). Reagents and plates were prepared accordingly to the manufacturer&#x02019;s standard procedure and incubated for 25 minutes under standard conditions. The degree of absorption was measured in a microplate reader Infinite<sup>&#x000ae;</sup> M200 PRO (Tecan Deutschland GmbH, Crailsheim, Germany).</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Statistical analysis of data was carried out using a two-way analysis of variance test (Statgraphics Plus version 4.1; Stat-Point Technologies, Inc, Warrenton, VA). The model included two factors (nano-Au and HS treatments) and interactions between the factors. Significant effects were stated when <italic>P</italic> &#x0003c; 0.05.</p></sec></sec></sec><sec><title>Results</title><p>In the present experiment, embryos treated with HS had lower mortality than other groups. Nano-Au, HS, and nano-Au+HS complex did not affect embryo weight or the weight of organs, except for the heart being slightly smaller with HS treatment (<xref ref-type="table" rid="t2-ijn-6-3163">Table 2</xref>). Furthermore, there was no significant effect on the measured biochemical indices in blood (<xref ref-type="table" rid="t3-ijn-6-3163">Table 3</xref>).</p><p>To examine the influence of nano-Au and HS on muscle development, the number of nuclei was determined (DAPI staining) in the breast muscle, showing increased number of nuclei in treated embryos (<xref ref-type="fig" rid="f2-ijn-6-3163">Figure 2</xref>). The counted number of nuclei was significantly higher in embryos treated with nano-Au and nano-Au+HS than in the control group, and there was highly significant interaction between nano-Au and HS treatments (<xref ref-type="table" rid="t4-ijn-6-3163">Table 4</xref>).</p><p>Breast muscle tissue was visualized by SEM, using the environmental SEM operating mode which allows observation with minimal distortion to the muscle structure. There were visual changes in the structure of the breast muscle in the groups treated with injections compared to the embryos from the control group (<xref ref-type="fig" rid="f3-ijn-6-3163">Figure 3</xref>). In the control group, the muscle fibers formed the most compact structure and the surface of individual muscle fascicles was smaller compared to the treatment groups. Furthermore, the distances between fascicles were greater and the area of fascicles was longer with sharper structures in the control group than in the treatment groups. Empty areas, which were seen around fascicles in the control group, were much smaller than in the treatment groups. In embryos treated with nano-Au, HS, and nano-Au+HS, muscle fibers were organized in more rounded and well-developed fascicles, located equally within muscle. In the HS-treated groups, the connective tissue seen between muscle fascicles was better developed than in the other embryos. The structure of the muscle cross-section in the nano-Au+HS group was the most homogeneous and mature. Fascicles were the most rounded and filled with myofibers. The space around them also showed better connective tissue structure.</p><p>The evaluation of the morphology of breast muscles was carried out using TEM. While analyzing transverse section images of muscle samples from the control group, an enlargement area was seen between cells and cells were more rounded and less angular with a slightly stippled cytoplasm. Within cells, cylindrical myofibrils were seen; however, in the control group they were loosely spaced with larger spaces between myofibers than in the treatment groups. Also, myomere decay, unification of actin and myosin filaments, loose connective tissue, and occasional myelin structures were observed (<xref ref-type="fig" rid="f4-ijn-6-3163">Figure 4</xref>). Muscles from the nano-Au group were characterized by contracted cells and bigger myocytes. In the muscles from the HS group, a higher number of satellite muscle cells were seen. Moreover, angular, homogeneous myofibers were observed close to each other. These muscles were more developed compared with the control group. In the muscles from the nano-Au+HS group, homogenous and closely located (packed) muscle cells were seen. Within cells, myofilaments were clearly seen and numerous mitochondria and a large number of satellite cells were also observed.</p><p>From the morphometric measurements, the number of satellite cells and muscle cells were determined (<xref ref-type="table" rid="t4-ijn-6-3163">Table 4</xref>). HS and nano-Au+HS increased the number of muscle cells and satellite cells, compared to the control and nano-Au groups.</p><p>To confirm the effects on the number of satellite cells, muscle samples were stained for <italic>Pax-7</italic> protein and observed with a confocal microscope (<xref ref-type="fig" rid="f5-ijn-6-3163">Figure 5</xref>). The muscles from embryos treated with HS and nano-Au+HS had a larger number of clusters of <italic>Pax-7</italic> protein than the muscles from the nano-Au and control groups.</p><p>To confirm the results on the molecular level, gene expression of <italic>Pax-7</italic> and <italic>FGF-2</italic> in the breast muscle was measured (<xref ref-type="table" rid="t5-ijn-6-3163">Table 5</xref>). At the mRNA level, HS significantly increased expression of <italic>Pax-7</italic> and significantly reduced the expression of <italic>FGF-2</italic>. However, there was no effect of nano-Au and no interaction between nano-Au and HS.</p></sec><sec><title>Discussion</title><p>In the present study, the chicken embryo was chosen as the animal model. It has a rapid rate of growth and its embryonic development is described in detail.<xref ref-type="bibr" rid="b21-ijn-6-3163">21</xref> The embryo is independent from the mother,<xref ref-type="bibr" rid="b22-ijn-6-3163">22</xref> it is highly sensitive to harmful factors,<xref ref-type="bibr" rid="b23-ijn-6-3163">23</xref> and it has been used as a suitable model for cancer therapy research,<xref ref-type="bibr" rid="b24-ijn-6-3163">24</xref> the determination of bacterial invasiveness,<xref ref-type="bibr" rid="b25-ijn-6-3163">25</xref> and new drug delivery systems development.<xref ref-type="bibr" rid="b26-ijn-6-3163">26</xref></p><p>Analysis of the present results led to the conclusion that administration of nano-Au, HS, and nano-Au+HS did not negatively affect the growth and development of chicken embryos. The results from other investigations suggest that, up to a certain concentration, nano-Au are not harmful to an organism, but with increasing concentrations they may have harmful effects.<xref ref-type="bibr" rid="b16-ijn-6-3163">16</xref>&#x02013;<xref ref-type="bibr" rid="b18-ijn-6-3163">18</xref>,<xref ref-type="bibr" rid="b27-ijn-6-3163">27</xref>,<xref ref-type="bibr" rid="b28-ijn-6-3163">28</xref> The present study was not undertaken to evaluate potential toxicity of nano-Au, however, it confirmed the lack of harmful effects of nano-Au administered in small quantities (concentration: 50 mg/L, dose: 500 &#x003bc;L). Nano-Au did not negatively affect development of embryos (mortality, organ weight, and homeostasis). Nevertheless, the present results are from a short term study over 20 days of embryogenesis; because nano-Au can penetrate most tissues,<xref ref-type="bibr" rid="b29-ijn-6-3163">29</xref>&#x02013;<xref ref-type="bibr" rid="b31-ijn-6-3163">31</xref> their potentially negative effects may take place later in life.</p><p>In comparison to Au, HS is a natural component of tissues and given at the concentration of 0.032 mg/L and the dose of 500 &#x003bc;L had no adverse effects on embryonic development; moreover, HS reduced the mortality of embryos and decreased the heart weight compared to the other groups. The heart develops from cardiomyocyte precursors and even at the beginning of embryogenesis works together with the developing outer network of blood vessels.<xref ref-type="bibr" rid="b22-ijn-6-3163">22</xref> According to Ausprunk,<xref ref-type="bibr" rid="b32-ijn-6-3163">32</xref> HS is involved in the differentiation and development of arterial and venous vessels of the chorioallantoic membrane. A key factor for vascular development is vascular endothelial growth factor.<xref ref-type="bibr" rid="b33-ijn-6-3163">33</xref> HS can partially activate an inactive form of vascular endothelial growth factor, prolonging its biological activity.<xref ref-type="bibr" rid="b34-ijn-6-3163">34</xref> Furthermore, addition of a sulfated oligosaccharide enhances angiogenesis and stabilizes the capillary network of new blood vessels.<xref ref-type="bibr" rid="b10-ijn-6-3163">10</xref>,<xref ref-type="bibr" rid="b35-ijn-6-3163">35</xref> Thus, a properly developed system of blood vessels of the correct diameter may decrease the resistance of peripheral vessels and, consequently, slightly decrease the force of heart contractions, leading to a proper heart weight. It should also be noted that the activity of alanine aminotransferase, aspartate aminotransferase, and other biochemical parameters of blood did not change, which otherwise could be the sign of distortion in the homeostasis of the organism, including the circulatory system.</p><p>Assessing the dynamics of muscle development, it was found that the total number of DAPI-labeled nuclei increased after in ovo HS injection, indicating enhanced dynamics of embryonic muscle development. Within the muscle tissue of the developing chicken embryo, nuclei of various cells can be observed: multinuclear muscle cells, connective tissue cells, blood cells, nerve cells, satellite cells, and other stem cells, but the muscle cells and muscle stem cells are dominant.<xref ref-type="bibr" rid="b2-ijn-6-3163">2</xref> The analysis of images obtained from SEM and TEM clearly showed an increase in the number of muscle cells after treatment with HS. To explain this phenomenon, two mechanisms could be considered; the first may indicate a scarcity of HS, which is essential for muscle development while the second may point to the stimulating effects of HS. In the present experiment, morphological defects seen in the control group may confirm the first mechanism that the quantity of HS or it precursors in the egg was not sufficient for optimal muscle development.</p><p>The mechanism of formation of muscle structures, depending on the chemical composition of the extracellular matrix, is not fully known. Myogenesis starts early in embryonic development and <italic>FGF-2</italic> plays a key role in mesoderm induction.<xref ref-type="bibr" rid="b36-ijn-6-3163">36</xref> This factor stimulates proliferation and inhibits cell differentiation<xref ref-type="bibr" rid="b37-ijn-6-3163">37</xref> by suppressing the transcription of myogenin.<xref ref-type="bibr" rid="b38-ijn-6-3163">38</xref> HS allows cells to bind <italic>FGF-2</italic> and with an increasing number of sulfur groups, the binding efficiency increases,<xref ref-type="bibr" rid="b39-ijn-6-3163">39</xref>,<xref ref-type="bibr" rid="b40-ijn-6-3163">40</xref> while a loss of sulfur groups blocks glycosaminoglycan activity.<xref ref-type="bibr" rid="b41-ijn-6-3163">41</xref> Inhibition of proliferation because of HS deficiency and premature cell differentiation is likely to reduce the number of cells in the final stages of embryonic development and ultimately may lead to defective tissue structure, especially in intensively growing organisms.<xref ref-type="bibr" rid="b42-ijn-6-3163">42</xref>,<xref ref-type="bibr" rid="b43-ijn-6-3163">43</xref></p><p>In the present experiment, expression of <italic>FGF-2</italic> at the mRNA level in the HS groups decreased more than fourfold compared to the control group. The evaluation of morphological and molecular indices of muscle development was carried out at day 20 of incubation, hence at the end of embryogenesis, just before hatching. On day 20 of embryonic development, the process of muscle development is almost finished and the number of muscle cells is almost stable. This was manifested by the reduced expression of <italic>FGF-2</italic> at mRNA level in HS muscles, indicating that the process of muscle fiber formation was completed. At the protein level, the concentration of <italic>FGF-2</italic> protein was not significantly affected by HS, probably because protein expression occurs as a consequence of gene expression and is associated with a delay.</p><p>The effect of HS on <italic>FGF-2</italic> expression at the mRNA level may be explained by an increased affinity of <italic>FGF-2</italic> for its receptor,<xref ref-type="bibr" rid="b44-ijn-6-3163">44</xref>&#x02013;<xref ref-type="bibr" rid="b46-ijn-6-3163">46</xref> thereby enhancing the <italic>FGF</italic>/FGF receptor interaction. It has also been demonstrated that both HS and heparin may increase the surface concentration of <italic>FGF-2</italic>, as well as assist in ligand dimerisation;<xref ref-type="bibr" rid="b46-ijn-6-3163">46</xref>&#x02013;<xref ref-type="bibr" rid="b48-ijn-6-3163">48</xref> consequently, signaling activities of <italic>FGF-2</italic> might be more efficient in muscles enriched with HS. On the other hand, other mechanisms have also been suggested. The results from Wiedlocha et al<xref ref-type="bibr" rid="b49-ijn-6-3163">49</xref> indicate a receptor-independent mechanism for <italic>FGF-1</italic> stimulation of proliferation. This may be true for <italic>FGF-2</italic> as both growth factors bind to similar receptors. Therefore, signals important for cell proliferation can be initiated either via the FGF receptors or independent of them. Furthermore, Quarto and Amalric<xref ref-type="bibr" rid="b50-ijn-6-3163">50</xref> reported that <italic>FGF-2</italic> stimulated plasminogen activator expression in L6 rat myoblasts devoid of functional FGF receptor. They suggested that the signal is transduced through HS proteoglycans. This may also explain the decreased mRNA expression of <italic>FGF-2</italic> in HS-treated embryos, which could have been caused by increased efficiency of <italic>FGF-2</italic> and thereby diminished the requirement for the synthesis of this molecule.</p><p>TEM image analysis showed an increased number of satellite cells in the muscles of embryos treated with HS. The regeneration of muscle fibers in the postnatal period is highly dependent on the number of satellite cells formed during embryogenesis. Furthermore, the number of muscle satellite cells decreases with age. In chickens, in the late phase of muscle growth, it declines to less than 5% of the total number of muscle fibers.<xref ref-type="bibr" rid="b51-ijn-6-3163">51</xref> Thus, an increased pool of these cells during embryogenesis may protect from muscle atrophy later in life.<xref ref-type="bibr" rid="b52-ijn-6-3163">52</xref></p><p>To elucidate the effect of HS on muscle development, a number of cells containing protein <italic>Pax-7</italic> and its gene expression at the mRNA level were estimated. <italic>Pax-7</italic> is localized in the nucleus of satellite cells and is a recognized marker of these cells.<xref ref-type="bibr" rid="b7-ijn-6-3163">7</xref> Treatments with HS contributed to the increased number of <italic>Pax-7</italic> positive cells and expression of the gene. In the present experiment, expression of <italic>FGF-2</italic> at the mRNA level, close to hatching, was decreased in the HS groups. This may be related to the <italic>Pax-3</italic> and <italic>Pax-7</italic> genes, which are indirectly involved in the down regulation of <italic>FGF-2</italic> via a feedback mechanism.<xref ref-type="bibr" rid="b53-ijn-6-3163">53</xref> Taking into consideration the fact that HS affected both the number of satellite cells as well as muscle cells, this indicates that HS modified the whole sequence of events during the maturation of muscles, increasing the formation of muscle fibers, and increasing the formation and incorporation of satellite cells in the breast muscle at the end of embryogenesis.</p><p>Assessing the impact of nano-Au on muscle development, it was measured that nano-Au increased the number of nuclei and enlarged the areas of fibers in the breast muscle. However, there was no effect of nano-Au on the number of satellite cells or on the number of muscle cells. These results may indicate that nano-Au could boost the number of nuclei in a single muscle fiber and/or increase the number of other cells. Certainly, more research is needed to elucidate the mechanisms of muscle fiber enlargement.</p><p>The present results have shown that cell and/or tissue requirements for functional compounds like sulfur-containing molecules may be a critical point for proper maturation and functioning of muscle. Moreover, nano-Au did not influence the homeostasis of the embryo organism, suggesting that they might be used as carriers of drugs and other bioactive compounds. Although these results were obtained from chicken embryos, which develop quickly, they indicate the potential applicability of HS, nano-Au, and complexes of these materials for nutritional and therapeutic procedures.</p></sec><sec><title>Conclusion</title><p>Nano-Au and HS, administered in ovo to chicken embryos on the first day of embryogenesis, did not adversely affect mortality, organ weight, and homeostasis of the embryos by day 20 of embryonic development. HS improved the development and maturation of breast muscle by increasing the number of myocytes, satellite cells, and nuclei, and by increasing area of muscle fibers. Furthermore, the nano-Au+HS complex contributed to the increased number of myocytes and nuclei, and enlarged area of muscle fibers. The results indicate that the administration of HS and nano-Au affects muscle development and that this effect is enhanced by conjugating HS with nano-Au.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by grants: &#x0201c;New, multifunctional nanopowder of carbon&#x0201d; 357/ERA-NET 2008&#x02013;2011 and Danish Agency for Science, Technology, and Innovation #2106-08-0025.</p></ack><fn-group><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ijn-6-3163"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zammit</surname><given-names>PS</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Nagata</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Pax7 and myogenic progression in skeletal muscle satellite cells</article-title><source>J Cell Sci</source><year>2006</year><volume>119</volume><issue>Pt 9</issue><fpage>1824</fpage><lpage>1832</lpage><pub-id pub-id-type="pmid">16608873</pub-id></element-citation></ref><ref id="b2-ijn-6-3163"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velleman</surname><given-names>SG</given-names></name></person-group><article-title>Muscle development in the embryo and hatchling</article-title><source>Poult Sci</source><year>2007</year><volume>86</volume><issue>5</issue><fpage>1050</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">17435046</pub-id></element-citation></ref><ref id="b3-ijn-6-3163"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>JE</given-names></name><name><surname>Partridge</surname><given-names>TA</given-names></name></person-group><article-title>Muscle satellite cells</article-title><source>Int J Biochem Cell Biol</source><year>2003</year><volume>35</volume><issue>8</issue><fpage>1151</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">12757751</pub-id></element-citation></ref><ref id="b4-ijn-6-3163"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>HD</given-names></name><name><surname>Goddard</surname><given-names>C</given-names></name></person-group><article-title>Rapidly growing broiler (meat-type) chickens. Their origin and use for comparative studies of the regulation of growth</article-title><source>Int J Biochem</source><year>1994</year><volume>26</volume><issue>1</issue><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">8138043</pub-id></element-citation></ref><ref id="b5-ijn-6-3163"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinnell</surname><given-names>IW</given-names></name><name><surname>Ishibashi</surname><given-names>J</given-names></name><name><surname>Le Grand</surname><given-names>F</given-names></name><etal/></person-group><article-title>Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">18066051</pub-id></element-citation></ref><ref id="b6-ijn-6-3163"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Sabourin</surname><given-names>LA</given-names></name><name><surname>Girgis-Gabardo</surname><given-names>A</given-names></name><name><surname>Mansouri</surname><given-names>A</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><article-title>Pax7 is required for the specification of myogenic satellite cells</article-title><source>Cell</source><year>2000</year><volume>102</volume><issue>6</issue><fpage>777</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">11030621</pub-id></element-citation></ref><ref id="b7-ijn-6-3163"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holterman</surname><given-names>CE</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><article-title>Molecular regulation of satellite cell function</article-title><source>Semin Cell Dev Biol</source><year>2005</year><volume>16</volume><issue>4&#x02013;5</issue><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">16095933</pub-id></element-citation></ref><ref id="b8-ijn-6-3163"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Kishioka</surname><given-names>Y</given-names></name><name><surname>Wakamatsu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Decorin binds myostatin and modulates its activity to muscle cells</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>340</volume><issue>2</issue><fpage>675</fpage><lpage>680</lpage><pub-id pub-id-type="pmid">16380093</pub-id></element-citation></ref><ref id="b9-ijn-6-3163"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumova</surname><given-names>S</given-names></name><name><surname>Woods</surname><given-names>A</given-names></name><name><surname>Couchman</surname><given-names>JR</given-names></name></person-group><article-title>Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions</article-title><source>Int J Biochem Cell Biol</source><year>2000</year><volume>32</volume><issue>3</issue><fpage>269</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">10716625</pub-id></element-citation></ref><ref id="b10-ijn-6-3163"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>MM</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mousa</surname><given-names>S</given-names></name><etal/></person-group><article-title>Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties</article-title><source>Nanotechnology</source><year>2009</year><volume>20</volume><issue>45</issue><fpage>455104</fpage><pub-id pub-id-type="pmid">19822927</pub-id></element-citation></ref><ref id="b11-ijn-6-3163"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanone</surname><given-names>S</given-names></name><name><surname>Boczkowski</surname><given-names>J</given-names></name></person-group><article-title>Biomedical applications and potential health risks of nanomaterials: molecular mechanisms</article-title><source>Curr Mol Med</source><year>2006</year><volume>6</volume><issue>6</issue><fpage>651</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">17022735</pub-id></element-citation></ref><ref id="b12-ijn-6-3163"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Han</surname><given-names>G</given-names></name><name><surname>De</surname><given-names>M</given-names></name><name><surname>Kima</surname><given-names>CK</given-names></name><name><surname>Rotello</surname><given-names>VM</given-names></name></person-group><article-title>Gold nanoparticles in delivery applications</article-title><source>Adv Drug Deliv Rev</source><year>2008</year><volume>60</volume><issue>11</issue><fpage>1307</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">18555555</pub-id></element-citation></ref><ref id="b13-ijn-6-3163"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>P</given-names></name><name><surname>Bhattacharya</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Antiangiogenic properties of gold nanoparticles</article-title><source>Clin Cancer Res</source><year>2005</year><volume>11</volume><issue>9</issue><fpage>3530</fpage><lpage>3534</lpage><pub-id pub-id-type="pmid">15867256</pub-id></element-citation></ref><ref id="b14-ijn-6-3163"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>De</surname><given-names>M</given-names></name><name><surname>Rotello</surname><given-names>VM</given-names></name></person-group><article-title>Drug and gene delivery using gold nanoparticles</article-title><source>Drug Deliv</source><year>2007</year><volume>3</volume><issue>1</issue><fpage>40</fpage><lpage>45</lpage></element-citation></ref><ref id="b15-ijn-6-3163"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>CJ</given-names></name><name><surname>Gole</surname><given-names>AM</given-names></name><name><surname>Stone</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Gold nanoparticles in biology: beyond toxicity to cellular imaging</article-title><source>Acc Chem Res</source><year>2008</year><volume>41</volume><issue>12</issue><fpage>1721</fpage><lpage>1730</lpage><pub-id pub-id-type="pmid">18712884</pub-id></element-citation></ref><ref id="b16-ijn-6-3163"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>EE</given-names></name><name><surname>Mwamuka</surname><given-names>J</given-names></name><name><surname>Gole</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>CJ</given-names></name><name><surname>Wyatt</surname><given-names>MD</given-names></name></person-group><article-title>Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity</article-title><source>Small</source><year>2005</year><volume>1</volume><issue>3</issue><fpage>325</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">17193451</pub-id></element-citation></ref><ref id="b17-ijn-6-3163"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>LM</given-names></name><name><surname>Lee</surname><given-names>KJ</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Nallathamby</surname><given-names>PD</given-names></name><name><surname>Lowman</surname><given-names>JE</given-names></name><name><surname>Xu</surname><given-names>XH</given-names></name></person-group><article-title>Random walk of single gold nanoparticles in zebrafish embryos leading to stochastic toxic effects on embryonic development</article-title><source>Nanoscale</source><year>2009</year><volume>1</volume><issue>1</issue><fpage>138</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">20644873</pub-id></element-citation></ref><ref id="b18-ijn-6-3163"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasagna-Reeves</surname><given-names>C</given-names></name><name><surname>Gonzalez-Romero</surname><given-names>D</given-names></name><name><surname>Barria</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice</article-title><source>Biochem Biophys Res Commun</source><year>2010</year><volume>393</volume><issue>4</issue><fpage>649</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">20153731</pub-id></element-citation></ref><ref id="b19-ijn-6-3163"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name></person-group><article-title>The first example of ordered two-dimensional self-assembly of Au nanoparticles from stable hydrosol</article-title><source>Langmuir</source><year>2004</year><volume>20</volume><issue>5</issue><fpage>1977</fpage><lpage>1979</lpage></element-citation></ref><ref id="b20-ijn-6-3163"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyrpassopoulos</surname><given-names>S</given-names></name><name><surname>Niarchos</surname><given-names>D</given-names></name><name><surname>Nounesis</surname><given-names>G</given-names></name><name><surname>Boukos</surname><given-names>N</given-names></name><name><surname>Zafiropoulou</surname><given-names>I</given-names></name><name><surname>Tzitzios</surname><given-names>V</given-names></name></person-group><article-title>Synthesis and self-organization of Au nanoparticles</article-title><source>Nanotechnology</source><year>2007</year><volume>18</volume><issue>48</issue><fpage>485604</fpage></element-citation></ref><ref id="b21-ijn-6-3163"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamburger</surname><given-names>V</given-names></name><name><surname>Hamilton</surname><given-names>HL</given-names></name></person-group><article-title>A series of normal stages in the development of the chick embryo</article-title><source>J Morphol</source><year>1951</year><volume>88</volume><issue>1</issue><fpage>49</fpage><lpage>92</lpage></element-citation></ref><ref id="b22-ijn-6-3163"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ribatti</surname><given-names>D</given-names></name></person-group><source>The Chick Embryo Chorioallantoic Membrane in the Study of Angiogenesis and Metastasis</source><publisher-loc>New York</publisher-loc><publisher-name>Springer Science+Business Media B.V</publisher-name><year>2010</year></element-citation></ref><ref id="b23-ijn-6-3163"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname><given-names>GH</given-names></name><name><surname>Hoffman</surname><given-names>DJ</given-names></name><name><surname>Klimstra</surname><given-names>JD</given-names></name><name><surname>Stebbins</surname><given-names>KR</given-names></name><name><surname>Kondrad</surname><given-names>SL</given-names></name><name><surname>Erwin</surname><given-names>CA</given-names></name></person-group><article-title>Species differences in the sensitivity of avian embryos to methylmercury</article-title><source>Arch Environ Contam Toxicol</source><year>2009</year><volume>56</volume><issue>1</issue><fpage>129</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">18421496</pub-id></element-citation></ref><ref id="b24-ijn-6-3163"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luyten</surname><given-names>GP</given-names></name><name><surname>Mooy</surname><given-names>CM</given-names></name><name><surname>De Jong</surname><given-names>PT</given-names></name><name><surname>Hoogeveen</surname><given-names>AT</given-names></name><name><surname>Luider</surname><given-names>TM</given-names></name></person-group><article-title>A chicken embryo model to study the growth of human uveal melanoma</article-title><source>Biochem Biophys Res Commun</source><year>1993</year><volume>192</volume><issue>1</issue><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">8476423</pub-id></element-citation></ref><ref id="b25-ijn-6-3163"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>PS</given-names></name><name><surname>Petermann</surname><given-names>SR</given-names></name><name><surname>Wooley</surname><given-names>RE</given-names></name></person-group><article-title>Comparison of several challenge models for studies in avian colibacillosis</article-title><source>Avian Dis</source><year>2004</year><volume>48</volume><issue>4</issue><fpage>751</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">15666856</pub-id></element-citation></ref><ref id="b26-ijn-6-3163"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>A</given-names></name><name><surname>Zeisser-Labou&#x000e8;be</surname><given-names>M</given-names></name><name><surname>Lange</surname><given-names>N</given-names></name><name><surname>Gurny</surname><given-names>R</given-names></name><name><surname>Delie</surname><given-names>F</given-names></name></person-group><article-title>The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems</article-title><source>Adv Drug Deliv Rev</source><year>2007</year><volume>59</volume><issue>11</issue><fpage>1162</fpage><lpage>1176</lpage><pub-id pub-id-type="pmid">17870202</pub-id></element-citation></ref><ref id="b27-ijn-6-3163"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pernodet</surname><given-names>N</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Adverse effects of citrate/gold nano-particles on human dermal fibroblasts</article-title><source>Small</source><year>2006</year><volume>2</volume><issue>6</issue><fpage>766</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">17193121</pub-id></element-citation></ref><ref id="b28-ijn-6-3163"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Ilan</surname><given-names>O</given-names></name><name><surname>Albrecht</surname><given-names>RM</given-names></name><name><surname>Fako</surname><given-names>VE</given-names></name><name><surname>Furgeson</surname><given-names>DY</given-names></name></person-group><article-title>Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos</article-title><source>Small</source><year>2009</year><volume>5</volume><issue>16</issue><fpage>1897</fpage><lpage>1910</lpage><pub-id pub-id-type="pmid">19437466</pub-id></element-citation></ref><ref id="b29-ijn-6-3163"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>WH</given-names></name><name><surname>Hagens</surname><given-names>WI</given-names></name><name><surname>Krystek</surname><given-names>P</given-names></name><name><surname>Burger</surname><given-names>MC</given-names></name><name><surname>Sips</surname><given-names>AJ</given-names></name><name><surname>Geertsma</surname><given-names>RE</given-names></name></person-group><article-title>Particle size-dependent organ distribution of gold nano-particles after intravenous administration</article-title><source>Biomaterials</source><year>2008</year><volume>29</volume><issue>12</issue><fpage>1912</fpage><lpage>1919</lpage><pub-id pub-id-type="pmid">18242692</pub-id></element-citation></ref><ref id="b30-ijn-6-3163"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonavane</surname><given-names>G</given-names></name><name><surname>Tomoda</surname><given-names>K</given-names></name><name><surname>Makino</surname><given-names>K</given-names></name></person-group><article-title>Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size</article-title><source>Colloids Surf B Biointerfaces</source><year>2008</year><volume>66</volume><issue>2</issue><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">18722754</pub-id></element-citation></ref><ref id="b31-ijn-6-3163"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Jing</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name></person-group><article-title>Concentration effect of gold nanoparticles on proliferation of keratinocytes</article-title><source>Colloids Surf B Biointerfaces</source><year>2010</year><volume>81</volume><issue>2</issue><fpage>406</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">20801623</pub-id></element-citation></ref><ref id="b32-ijn-6-3163"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ausprunk</surname><given-names>DH</given-names></name></person-group><article-title>Distribution of hyaluronic acid and sulfated glycosaminoglycans during blood-vessel development in the chick chorioallantoic membrane</article-title><source>Am J Anat</source><year>1986</year><volume>177</volume><issue>3</issue><fpage>313</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">2432769</pub-id></element-citation></ref><ref id="b33-ijn-6-3163"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yancopoulos</surname><given-names>GD</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Gale</surname><given-names>NW</given-names></name><name><surname>Rudge</surname><given-names>JS</given-names></name><name><surname>Wiegand</surname><given-names>SJ</given-names></name><name><surname>Holash</surname><given-names>J</given-names></name></person-group><article-title>Vascular-specific growth factors and blood vessels formation</article-title><source>Nature</source><year>2000</year><volume>407</volume><issue>6801</issue><fpage>242</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">11001067</pub-id></element-citation></ref><ref id="b34-ijn-6-3163"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>CJ</given-names></name><name><surname>Stringer</surname><given-names>SE</given-names></name></person-group><article-title>The splice variants of vascular endothelial growth factor (VEGF) and their receptors</article-title><source>J Cell Sci</source><year>2001</year><volume>114</volume><issue>Pt 5</issue><fpage>853</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">11181169</pub-id></element-citation></ref><ref id="b35-ijn-6-3163"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousa</surname><given-names>SA</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><etal/></person-group><article-title>Synthetic oligosaccharide stimulates and stabilizes angiogenesis: structure-function relationships and potential mechanisms</article-title><source>Cardiovasc Pharmacol</source><year>2006</year><volume>48</volume><issue>2</issue><fpage>6</fpage><lpage>13</lpage></element-citation></ref><ref id="b36-ijn-6-3163"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>HV</given-names></name><name><surname>Tannahill</surname><given-names>D</given-names></name><name><surname>Slack</surname><given-names>JM</given-names></name></person-group><article-title>Expression of a novel FGF in the Xenopus embryo. A new candidate inducing factor for mesoderm formation and anterioposterior specification</article-title><source>Development</source><year>1992</year><volume>114</volume><issue>3</issue><fpage>711</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">1618138</pub-id></element-citation></ref><ref id="b37-ijn-6-3163"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>RE</given-names></name><name><surname>Goll</surname><given-names>DE</given-names></name></person-group><article-title>Cellular and developmental biology of skeletal muscle as related to muscle growth</article-title><person-group person-group-type="editor"><name><surname>Scanes</surname><given-names>C</given-names></name></person-group><source>Biology of Growth of Domestic Animals</source><publisher-loc>Ames, IA</publisher-loc><publisher-name>Iowa State Press</publisher-name><year>2003</year><fpage>148</fpage><lpage>169</lpage></element-citation></ref><ref id="b38-ijn-6-3163"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunetti</surname><given-names>A</given-names></name><name><surname>Goldfine</surname><given-names>ID</given-names></name></person-group><article-title>Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor</article-title><source>J Biol Chem</source><year>1990</year><volume>265</volume><issue>11</issue><fpage>5960</fpage><lpage>5963</lpage><pub-id pub-id-type="pmid">1690720</pub-id></element-citation></ref><ref id="b39-ijn-6-3163"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernfield</surname><given-names>M</given-names></name><name><surname>G&#x000f6;tte</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>PW</given-names></name><etal/></person-group><article-title>Functions of cell surface heparan sulfate proteoglycans</article-title><source>Annu Rev Biochem</source><year>1999</year><volume>68</volume><fpage>729</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">10872465</pub-id></element-citation></ref><ref id="b40-ijn-6-3163"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjellen</surname><given-names>L</given-names></name><name><surname>Lindahl</surname><given-names>U</given-names></name></person-group><article-title>Proteoglycans: structures and interactions</article-title><source>Annu Rev Biochem</source><year>1991</year><volume>60</volume><fpage>443</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">1883201</pub-id></element-citation></ref><ref id="b41-ijn-6-3163"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casu</surname><given-names>B</given-names></name><name><surname>Guerrini</surname><given-names>M</given-names></name><name><surname>Guglieri</surname><given-names>S</given-names></name><etal/></person-group><article-title>Undersulfated and glycol-split heparins endowed with antiangiogenic activity</article-title><source>J Med Chem</source><year>2004</year><volume>47</volume><issue>4</issue><fpage>838</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">14761186</pub-id></element-citation></ref><ref id="b42-ijn-6-3163"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Gherardi</surname><given-names>E</given-names></name></person-group><article-title>Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase</article-title><source>Trends Cell Biol</source><year>1998</year><volume>8</volume><issue>10</issue><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">9789329</pub-id></element-citation></ref><ref id="b43-ijn-6-3163"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cool</surname><given-names>SM</given-names></name><name><surname>Nurcombe</surname><given-names>V</given-names></name></person-group><article-title>Heparan sulfate regulation of progenitor cell fate</article-title><source>J Cell Biochem</source><year>2006</year><volume>99</volume><issue>4</issue><fpage>1040</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">16767693</pub-id></element-citation></ref><ref id="b44-ijn-6-3163"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantoliano</surname><given-names>MW</given-names></name><name><surname>Horlick</surname><given-names>RA</given-names></name><name><surname>Springer</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization</article-title><source>Biochemistry</source><year>1994</year><volume>33</volume><issue>34</issue><fpage>10229</fpage><lpage>10248</lpage><pub-id pub-id-type="pmid">7520751</pub-id></element-citation></ref><ref id="b45-ijn-6-3163"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roghani</surname><given-names>M</given-names></name><name><surname>Mansukhani</surname><given-names>A</given-names></name><name><surname>Dell&#x02019;Era</surname><given-names>P</given-names></name><etal/></person-group><article-title>Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><issue>6</issue><fpage>3976</fpage><lpage>3984</lpage><pub-id pub-id-type="pmid">8307953</pub-id></element-citation></ref><ref id="b46-ijn-6-3163"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>L</given-names></name></person-group><article-title>Role of heparan sulfate in fibroblast growth factor signaling: a structural view</article-title><source>Curr Opin Struct Biol</source><year>2001</year><volume>11</volume><issue>5</issue><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">11785766</pub-id></element-citation></ref><ref id="b47-ijn-6-3163"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>FGFs, heparan sulfate and FGFRs: complex interactions essential for development</article-title><source>Bioessays</source><year>2000</year><volume>22</volume><issue>2</issue><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">10655030</pub-id></element-citation></ref><ref id="b48-ijn-6-3163"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Plotnikov</surname><given-names>N</given-names></name><name><surname>Ibrahimi</surname><given-names>OA</given-names></name><etal/></person-group><article-title>Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding dimerization</article-title><source>Mol Cell</source><year>2000</year><volume>6</volume><issue>3</issue><fpage>743</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">11030354</pub-id></element-citation></ref><ref id="b49-ijn-6-3163"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedlocha</surname><given-names>A</given-names></name><name><surname>Falnes</surname><given-names>PO</given-names></name><name><surname>Madshus</surname><given-names>IH</given-names></name><name><surname>Sandvig</surname><given-names>K</given-names></name><name><surname>Olsnes</surname><given-names>S</given-names></name></person-group><article-title>Dual mode of signal transduction by externally added acidic fibroblast growth factor</article-title><source>Cell</source><year>1994</year><volume>76</volume><issue>6</issue><fpage>1039</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">7511061</pub-id></element-citation></ref><ref id="b50-ijn-6-3163"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quarto</surname><given-names>N</given-names></name><name><surname>Amalric</surname><given-names>F</given-names></name></person-group><article-title>Heparan sulfate proteoglycans are transducers of FGF-2 signaling</article-title><source>J Cell Sci</source><year>1994</year><volume>107</volume><issue>Pt 11</issue><fpage>3201</fpage><lpage>3212</lpage><pub-id pub-id-type="pmid">7699017</pub-id></element-citation></ref><ref id="b51-ijn-6-3163"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawke</surname><given-names>TJ</given-names></name><name><surname>Garry</surname><given-names>DJ</given-names></name></person-group><article-title>Myogenic satellite cells: physiology to molecular biology</article-title><source>J Appl Physiol</source><year>2001</year><volume>91</volume><issue>2</issue><fpage>534</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">11457764</pub-id></element-citation></ref><ref id="b52-ijn-6-3163"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Mitch</surname><given-names>WE</given-names></name></person-group><article-title>Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy</article-title><source>J Am Soc Nephrol</source><year>2010</year><volume>21</volume><issue>3</issue><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">20056750</pub-id></element-citation></ref><ref id="b53-ijn-6-3163"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagha</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Bajard</surname><given-names>L</given-names></name><etal/></person-group><article-title>Regulation of skeletal muscle stem cell behavior by Pax3 and Pax7</article-title><source>Cold Spring Harb Symp Quant Biol</source><year>2008</year><volume>73</volume><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">19022756</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ijn-6-3163" position="float"><label>Figure 1</label><caption><p>Image of hydrocolloid of gold nanoparticles visualized using transmission electron microscopy.</p></caption><graphic xlink:href="ijn-6-3163f1"/></fig><fig id="f2-ijn-6-3163" position="float"><label>Figure 2</label><caption><p>Images of nuclei (blue), stained with 4&#x02032;,6-diamidino-2-phenylindole, in the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using a confocal microscope. (<bold>A</bold>) Control, (<bold>B</bold>) gold nanoparticles, (<bold>C</bold>) heparan sulfate, and (<bold>D</bold>) gold nanoparticles and heparan sulfate complex.</p></caption><graphic xlink:href="ijn-6-3163f2"/></fig><fig id="f3-ijn-6-3163" position="float"><label>Figure 3</label><caption><p>Images of the ultrastructure of the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using scanning electron microscopy (environmental scanning electron microscope mode). (<bold>A</bold>) Control, (<bold>B</bold>) gold nanoparticles, (<bold>C</bold>) heparan sulfate, and (<bold>D</bold>) gold nanoparticles and heparan sulfate complex.</p></caption><graphic xlink:href="ijn-6-3163f3"/></fig><fig id="f4-ijn-6-3163" position="float"><label>Figure 4</label><caption><p>Images of the ultrastructure of the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using transmission electron microscopy. (<bold>A</bold>) Control, (<bold>B</bold>) gold nanoparticles, (<bold>C</bold>) heparan sulfate, and (<bold>D</bold>) gold nanoparticles and heparan sulfate complex.</p></caption><graphic xlink:href="ijn-6-3163f4"/></fig><fig id="f5-ijn-6-3163" position="float"><label>Figure 5</label><caption><p>Images of Pax-7 positive nuclei, shown as an overlaid image of 4&#x02032;,6-diamidino-2-phenylindole-stained nuclei (blue) and Pax-7 nuclei stained with fluorescein isothiocyanate (green), in the cross-section of the breast muscle of a chicken embryo on day 20 of incubation visualized using a confocal microscope. (<bold>A</bold>) Control, (<bold>B</bold>) gold nanoparticles, (<bold>C</bold>) heparan sulfate, and (<bold>D</bold>) gold nanoparticles and heparan sulfate complex.</p></caption><graphic xlink:href="ijn-6-3163f5"/></fig><table-wrap id="t1-ijn-6-3163" position="float"><label>Table 1</label><caption><p>Oligonucleotide sequences used in polymerase chain reaction</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">Size</th><th align="left" valign="top" rowspan="1" colspan="1">Primer sequences (5&#x02032; to 3&#x02032;)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>ACTB</italic></td><td align="left" valign="top" rowspan="1" colspan="1">ca. 169 bp</td><td align="left" valign="top" rowspan="1" colspan="1">Forward: GTC CAC CTT CCA GCA GAT GT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Reverse: ATA AAG CCA TGC CAA TCT CG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>EEF1-</italic>&#x003b1;</td><td align="left" valign="top" rowspan="1" colspan="1">ca. 85 bp</td><td align="left" valign="top" rowspan="1" colspan="1">Forward: AGC AGA CTT TGT GAC CTT GCC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Reverse: TGA CAT GAG ACA GAC GGT TGC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>FGF-2</italic></td><td align="left" valign="top" rowspan="1" colspan="1">ca. 151 bp</td><td align="left" valign="top" rowspan="1" colspan="1">Forward: GGC ACT GAA ATG TGC AAC AG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Reverse: TCC AGG TCC AGT TTT TGG TC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>PAX-7</italic></td><td align="left" valign="top" rowspan="1" colspan="1">ca. 135 bp</td><td align="left" valign="top" rowspan="1" colspan="1">Forward: CCA GTA GAG ACA GGC CAA GC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Reverse: GGA GTT GGG AAG GAG TAG GG</td></tr></tbody></table></table-wrap><table-wrap id="t2-ijn-6-3163" position="float"><label>Table 2</label><caption><p>Mortality and average weight of embryos and organs without (&#x02013;) or with gold nanoparticles and heparan sulfate</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Treatment</th><th colspan="5" align="left" valign="top" rowspan="1">ANOVA</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th colspan="5" align="left" valign="top" rowspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1">Without HS</th><th colspan="2" align="left" valign="top" rowspan="1">With HS</th><th colspan="4" align="left" valign="top" rowspan="1">Effect</th><th align="left" valign="top" rowspan="1" colspan="1">Interaction</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">HS</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Mortality, %</td><td align="left" valign="top" rowspan="1" colspan="1">13.6</td><td align="left" valign="top" rowspan="1" colspan="1">15.6</td><td align="left" valign="top" rowspan="1" colspan="1">9.52</td><td align="left" valign="top" rowspan="1" colspan="1">8.33</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Embryo, % e.w</td><td align="left" valign="top" rowspan="1" colspan="1">85.1</td><td align="left" valign="top" rowspan="1" colspan="1">84.9</td><td align="left" valign="top" rowspan="1" colspan="1">85.0</td><td align="left" valign="top" rowspan="1" colspan="1">85.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.615</td><td align="left" valign="top" rowspan="1" colspan="1">0.29</td><td align="left" valign="top" rowspan="1" colspan="1">0.917</td><td align="left" valign="top" rowspan="1" colspan="1">0.26</td><td align="left" valign="top" rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Liver, % b.w</td><td align="left" valign="top" rowspan="1" colspan="1">1.66</td><td align="left" valign="top" rowspan="1" colspan="1">1.75</td><td align="left" valign="top" rowspan="1" colspan="1">1.72</td><td align="left" valign="top" rowspan="1" colspan="1">1.69</td><td align="left" valign="top" rowspan="1" colspan="1">0.074</td><td align="left" valign="top" rowspan="1" colspan="1">0.030</td><td align="left" valign="top" rowspan="1" colspan="1">0.447</td><td align="left" valign="top" rowspan="1" colspan="1">0.029</td><td align="left" valign="top" rowspan="1" colspan="1">0.613</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart, % b.w</td><td align="left" valign="top" rowspan="1" colspan="1">0.60</td><td align="left" valign="top" rowspan="1" colspan="1">0.59</td><td align="left" valign="top" rowspan="1" colspan="1">0.63</td><td align="left" valign="top" rowspan="1" colspan="1">0.56</td><td align="left" valign="top" rowspan="1" colspan="1">0.347</td><td align="left" valign="top" rowspan="1" colspan="1">0.011</td><td align="left" valign="top" rowspan="1" colspan="1">0.002</td><td align="left" valign="top" rowspan="1" colspan="1">0.013</td><td align="left" valign="top" rowspan="1" colspan="1">0.099</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Spleen, % b.w</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.066</td><td align="left" valign="top" rowspan="1" colspan="1">0.002</td><td align="left" valign="top" rowspan="1" colspan="1">0.094</td><td align="left" valign="top" rowspan="1" colspan="1">0.002</td><td align="left" valign="top" rowspan="1" colspan="1">0.844</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ijn-6-3163"><p><bold>Abbreviations:</bold> % e.w, % of egg weight; % b.w, % of body weight; ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ijn-6-3163" position="float"><label>Table 3</label><caption><p>Biochemical indices in the blood serum of chicken embryos without (&#x02013;) or with gold nanoparticles and heparan sulfate</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Treatment</th><th colspan="5" align="left" valign="top" rowspan="1">ANOVA</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th colspan="5" align="left" valign="top" rowspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1">Without HS</th><th colspan="2" align="left" valign="top" rowspan="1">With HS</th><th colspan="4" align="left" valign="top" rowspan="1">Effect</th><th align="left" valign="top" rowspan="1" colspan="1">Interaction</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">HS</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Magnesium (mmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">0.75</td><td align="left" valign="top" rowspan="1" colspan="1">0.88</td><td align="left" valign="top" rowspan="1" colspan="1">0.75</td><td align="left" valign="top" rowspan="1" colspan="1">0.88</td><td align="left" valign="top" rowspan="1" colspan="1">0.702</td><td align="left" valign="top" rowspan="1" colspan="1">0.516</td><td align="left" valign="top" rowspan="1" colspan="1">0.477</td><td align="left" valign="top" rowspan="1" colspan="1">0.129</td><td align="left" valign="top" rowspan="1" colspan="1">0.882</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Calcium (mmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">2.70</td><td align="left" valign="top" rowspan="1" colspan="1">2.71</td><td align="left" valign="top" rowspan="1" colspan="1">2.45</td><td align="left" valign="top" rowspan="1" colspan="1">2.96</td><td align="left" valign="top" rowspan="1" colspan="1">0.980</td><td align="left" valign="top" rowspan="1" colspan="1">0.136</td><td align="left" valign="top" rowspan="1" colspan="1">0.092</td><td align="left" valign="top" rowspan="1" colspan="1">0.038</td><td align="left" valign="top" rowspan="1" colspan="1">0.752</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Phosphorus (mmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">1.73</td><td align="left" valign="top" rowspan="1" colspan="1">1.69</td><td align="left" valign="top" rowspan="1" colspan="1">1.71</td><td align="left" valign="top" rowspan="1" colspan="1">1.70</td><td align="left" valign="top" rowspan="1" colspan="1">0.651</td><td align="left" valign="top" rowspan="1" colspan="1">0.060</td><td align="left" valign="top" rowspan="1" colspan="1">0.916</td><td align="left" valign="top" rowspan="1" colspan="1">0.059</td><td align="left" valign="top" rowspan="1" colspan="1">0.751</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Triglycerides (mmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">0.78</td><td align="left" valign="top" rowspan="1" colspan="1">0.75</td><td align="left" valign="top" rowspan="1" colspan="1">0.79</td><td align="left" valign="top" rowspan="1" colspan="1">0.73</td><td align="left" valign="top" rowspan="1" colspan="1">0.714</td><td align="left" valign="top" rowspan="1" colspan="1">0.062</td><td align="left" valign="top" rowspan="1" colspan="1">0.529</td><td align="left" valign="top" rowspan="1" colspan="1">0.062</td><td align="left" valign="top" rowspan="1" colspan="1">0.962</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cholesterol-VLDL (mmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">0.35</td><td align="left" valign="top" rowspan="1" colspan="1">0.35</td><td align="left" valign="top" rowspan="1" colspan="1">0.36</td><td align="left" valign="top" rowspan="1" colspan="1">0.34</td><td align="left" valign="top" rowspan="1" colspan="1">0.904</td><td align="left" valign="top" rowspan="1" colspan="1">0.039</td><td align="left" valign="top" rowspan="1" colspan="1">0.740</td><td align="left" valign="top" rowspan="1" colspan="1">0.036</td><td align="left" valign="top" rowspan="1" colspan="1">0.928</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glucose (mmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">10.6</td><td align="left" valign="top" rowspan="1" colspan="1">10.2</td><td align="left" valign="top" rowspan="1" colspan="1">10.1</td><td align="left" valign="top" rowspan="1" colspan="1">10.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.502</td><td align="left" valign="top" rowspan="1" colspan="1">0.51</td><td align="left" valign="top" rowspan="1" colspan="1">0.689</td><td align="left" valign="top" rowspan="1" colspan="1">0.507</td><td align="left" valign="top" rowspan="1" colspan="1">0.899</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alkaline phosphatase (U/L)</td><td align="left" valign="top" rowspan="1" colspan="1">658</td><td align="left" valign="top" rowspan="1" colspan="1">636</td><td align="left" valign="top" rowspan="1" colspan="1">567</td><td align="left" valign="top" rowspan="1" colspan="1">727</td><td align="left" valign="top" rowspan="1" colspan="1">0.812</td><td align="left" valign="top" rowspan="1" colspan="1">64.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.093</td><td align="left" valign="top" rowspan="1" colspan="1">54.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.620</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aspartate aminotransferase (U/L)</td><td align="left" valign="top" rowspan="1" colspan="1">144</td><td align="left" valign="top" rowspan="1" colspan="1">162</td><td align="left" valign="top" rowspan="1" colspan="1">181</td><td align="left" valign="top" rowspan="1" colspan="1">125</td><td align="left" valign="top" rowspan="1" colspan="1">0.512</td><td align="left" valign="top" rowspan="1" colspan="1">19.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.050</td><td align="left" valign="top" rowspan="1" colspan="1">29.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.138</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alanine aminotransferase (U/L)</td><td align="left" valign="top" rowspan="1" colspan="1">11.7</td><td align="left" valign="top" rowspan="1" colspan="1">10.2</td><td align="left" valign="top" rowspan="1" colspan="1">13.2</td><td align="left" valign="top" rowspan="1" colspan="1">8.70</td><td align="left" valign="top" rowspan="1" colspan="1">0.527</td><td align="left" valign="top" rowspan="1" colspan="1">1.707</td><td align="left" valign="top" rowspan="1" colspan="1">0.075</td><td align="left" valign="top" rowspan="1" colspan="1">1.88</td><td align="left" valign="top" rowspan="1" colspan="1">0.839</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lactate dehydrogenase (U/L)</td><td align="left" valign="top" rowspan="1" colspan="1">2720</td><td align="left" valign="top" rowspan="1" colspan="1">3047</td><td align="left" valign="top" rowspan="1" colspan="1">2945</td><td align="left" valign="top" rowspan="1" colspan="1">2822</td><td align="left" valign="top" rowspan="1" colspan="1">0.223</td><td align="left" valign="top" rowspan="1" colspan="1">184.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.643</td><td align="left" valign="top" rowspan="1" colspan="1">192.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.399</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ijn-6-3163"><p><bold>Abbreviations:</bold> ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean; VLDL, very-low-density lipoprotein.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-ijn-6-3163" position="float"><label>Table 4</label><caption><p>Morphometry of the breast muscle of chicken embryos without (&#x02013;) or with gold nanoparticles and heparan sulfate</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Treatment</th><th colspan="5" align="left" valign="top" rowspan="1">ANOVA</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th colspan="5" align="left" valign="top" rowspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1">Without HS</th><th colspan="2" align="left" valign="top" rowspan="1">With HS</th><th colspan="4" align="left" valign="top" rowspan="1">Effect</th><th align="left" valign="top" rowspan="1" colspan="1">Interaction</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">HS</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of myocytes/10,000 &#x003bc;m<sup>2</sup><xref ref-type="table-fn" rid="tfn3-ijn-6-3163">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">23.0</td><td align="left" valign="top" rowspan="1" colspan="1">27.5</td><td align="left" valign="top" rowspan="1" colspan="1">18.5</td><td align="left" valign="top" rowspan="1" colspan="1">32.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.197</td><td align="left" valign="top" rowspan="1" colspan="1">3.21</td><td align="left" valign="top" rowspan="1" colspan="1">0.0000</td><td align="left" valign="top" rowspan="1" colspan="1">2.88</td><td align="left" valign="top" rowspan="1" colspan="1">0.024</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of satellite cells/10,000 &#x003bc;m<sup>2</sup><xref ref-type="table-fn" rid="tfn3-ijn-6-3163">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">7.1</td><td align="left" valign="top" rowspan="1" colspan="1">8.4</td><td align="left" valign="top" rowspan="1" colspan="1">6.8</td><td align="left" valign="top" rowspan="1" colspan="1">8.7</td><td align="left" valign="top" rowspan="1" colspan="1">0.213</td><td align="left" valign="top" rowspan="1" colspan="1">0.91</td><td align="left" valign="top" rowspan="1" colspan="1">0.0330</td><td align="left" valign="top" rowspan="1" colspan="1">0.72</td><td align="left" valign="top" rowspan="1" colspan="1">0.452</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fiber area (&#x003bc;m<sup>2</sup>)<xref ref-type="table-fn" rid="tfn3-ijn-6-3163">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">19.9</td><td align="left" valign="top" rowspan="1" colspan="1">25.0</td><td align="left" valign="top" rowspan="1" colspan="1">19.2</td><td align="left" valign="top" rowspan="1" colspan="1">21.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.002</td><td align="left" valign="top" rowspan="1" colspan="1">1.06</td><td align="left" valign="top" rowspan="1" colspan="1">0.0007</td><td align="left" valign="top" rowspan="1" colspan="1">1.30</td><td align="left" valign="top" rowspan="1" colspan="1">0.023</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Number of nuclei/10,000 &#x003bc;m<sup>2</sup><xref ref-type="table-fn" rid="tfn4-ijn-6-3163">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">16.1</td><td align="left" valign="top" rowspan="1" colspan="1">19.7</td><td align="left" valign="top" rowspan="1" colspan="1">15.7</td><td align="left" valign="top" rowspan="1" colspan="1">21.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.004</td><td align="left" valign="top" rowspan="1" colspan="1">0.84</td><td align="left" valign="top" rowspan="1" colspan="1">0.0009</td><td align="left" valign="top" rowspan="1" colspan="1">1.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.0009</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-ijn-6-3163"><label>*</label><p><bold>Notes:</bold> Transmission electron microscope;</p></fn><fn id="tfn4-ijn-6-3163"><label>**</label><p>confocal microscope.</p></fn><fn id="tfn5-ijn-6-3163"><p><bold>Abbreviations:</bold> ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-ijn-6-3163" position="float"><label>Table 5</label><caption><p>Expression of <italic>PAX-7</italic> and <italic>FGF-2</italic> on the messenger ribonucleic acid level, normalized to <italic>ACTB</italic>, and on the protein level in the breast muscle of chicken embryos without (&#x02013;) or with gold nanoparticles and heparan sulfate</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1">Treatment</th><th colspan="5" align="left" valign="top" rowspan="1">ANOVA</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th colspan="5" align="left" valign="top" rowspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1">Without HS</th><th colspan="2" align="left" valign="top" rowspan="1">HS</th><th colspan="4" align="left" valign="top" rowspan="1">Effect</th><th align="left" valign="top" rowspan="1" colspan="1">Interaction</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="4" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th align="left" valign="top" rowspan="1" colspan="1">&#x02013;</th><th align="left" valign="top" rowspan="1" colspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">Nano-Au</th><th colspan="2" align="left" valign="top" rowspan="1">HS</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th colspan="2" align="left" valign="top" rowspan="1"><hr/></th><th align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" valign="top" rowspan="1" colspan="1">SEM</th><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>PAX-7</italic><xref ref-type="table-fn" rid="tfn6-ijn-6-3163">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.80</td><td align="left" valign="top" rowspan="1" colspan="1">0.98</td><td align="left" valign="top" rowspan="1" colspan="1">0.57</td><td align="left" valign="top" rowspan="1" colspan="1">1.21</td><td align="left" valign="top" rowspan="1" colspan="1">0.435</td><td align="left" valign="top" rowspan="1" colspan="1">0.156</td><td align="left" valign="top" rowspan="1" colspan="1">0.0086</td><td align="left" valign="top" rowspan="1" colspan="1">0.358</td><td align="left" valign="top" rowspan="1" colspan="1">0.845</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>FGF-2</italic><xref ref-type="table-fn" rid="tfn6-ijn-6-3163">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">2.63</td><td align="left" valign="top" rowspan="1" colspan="1">2.70</td><td align="left" valign="top" rowspan="1" colspan="1">4.40</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.950</td><td align="left" valign="top" rowspan="1" colspan="1">0.705</td><td align="left" valign="top" rowspan="1" colspan="1">0.0024</td><td align="left" valign="top" rowspan="1" colspan="1">0.117</td><td align="left" valign="top" rowspan="1" colspan="1">0.806</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>FGF-2</italic> pg/mg protein<xref ref-type="table-fn" rid="tfn7-ijn-6-3163">**</xref></td><td align="left" valign="top" rowspan="1" colspan="1">132</td><td align="left" valign="top" rowspan="1" colspan="1">127</td><td align="left" valign="top" rowspan="1" colspan="1">144</td><td align="left" valign="top" rowspan="1" colspan="1">118</td><td align="left" valign="top" rowspan="1" colspan="1">0.716</td><td align="left" valign="top" rowspan="1" colspan="1">8.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.217</td><td align="left" valign="top" rowspan="1" colspan="1">10.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.119</td></tr></tbody></table><table-wrap-foot><fn id="tfn6-ijn-6-3163"><label>*</label><p><bold>Notes:</bold> Messenger ribonucleic acid level;</p></fn><fn id="tfn7-ijn-6-3163"><label>**</label><p>protein level.</p></fn><fn id="tfn8-ijn-6-3163"><p><bold>Abbreviations:</bold> ANOVA, analysis of variance; HS, heparan sulfate; nano-Au, gold nanoparticles; SEM, standard error of the mean.</p></fn></table-wrap-foot></table-wrap></floats-group></article>